share_log

Earnings Call Summary | Cutera(CUTR.US) Q1 2024 Earnings Conference

Futu News ·  May 10 22:23  · Conference Call

The following is a summary of the Cutera, Inc. (CUTR) Q1 2024 Earnings Call Transcript:

Financial Performance:

  • Cutera reported Q1 revenue of $38.8 million, a decrease from both the same period in 2023 and Q4 of 2023.

  • The gross margin rate also declined to 38.2% compared to 43.5% for the same period the previous year.

  • Non-GAAP loss from operations increased to $20.4 million in Q1 2024.

  • Cash balance decreased to $105.4 million.

Business Progress:

  • Cutera launched the AviClear technology and xeo+ to the North American market, both of which received positive feedback.

  • Major focus areas for Cutera include operational excellence, customer partnerships, revenue maintenance, and field force expansion.

  • Cutera is exploring the Australian market for AviClear and is investing in its clinical expansion.

  • Despite a decline in body contouring sales due to GLP-1 drugs, Cutera expects a resurgence as these temporary effects subside.

More details: Cutera IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment